Edition:
United Kingdom

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

0.92USD
3:51pm BST
Change (% chg)

$0.01 (+0.71%)
Prev Close
$0.91
Open
$0.93
Day's High
$0.94
Day's Low
$0.89
Volume
33,292
Avg. Vol
20,678
52-wk High
$6.45
52-wk Low
$0.84

Chart for

About

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based... (more)

Overall

Beta: --
Market Cap(Mil.): $159.70
Shares Outstanding(Mil.): 29.71
Dividend: --
Yield (%): --

Financials

  LIFE.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -2.19 -- --
ROI: -75.04 1.57 14.38
ROE: -82.03 2.43 16.07

BRIEF-Atyr Pharma Q4 Loss Per Share $0.39

* ATYR PHARMA ANNOUNCES FOURTH QUARTER AND YEAR-END 2017 OPERATING RESULTS AND PROVIDES CORPORATE UPDATE

19 Mar 2018

BRIEF-Atyr Pharma Says On Dec 22, Co Entered Into Amendment To Loan And Security Agreement Dated As Of Nov 18, 2016

* ATYR PHARMA SAYS ON DEC 22, CO ENTERED INTO AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED AS OF NOV 18, 2016 - SEC FILING

22 Dec 2017

Earnings vs. Estimates